Work

Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian Cancer

Year: 2019

Type: article

Abstract: clinical-guidelines/solution/radiation- oncology/healthplan/mvp-radiation-therapy_v102019_eff03012019_pub- 1122018.pdf.

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2019.1943

Authors: Emil Lou, Rachel I. Vogel, Spencer Hoostal, Molly Klein, Michael A. Linden, Deanna Teoh, Melissa A. Geller

Institution: University of Minnesota

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, American Cancer Society, Minnesota Ovarian Cancer Alliance, Celgene, University of Minnesota, Novocure, NRG Oncology, National Institutes of Health, Genentech, Clinical and Translational Science Institute, University of Minnesota, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G1345980661, University of Minnesota Clinical and Translational Science Institute (UMN CTSI), G2122139122, G235943272, G3070582560, G860459520, G9000002454, G9000050945

OpenAlex ID: W2946965067

FWCI: 1.594

Cites: 6

Cited by: 36

Related to: 10